Thoracic aortic aneurysms are correlated with significant mortality and morbidity. No therapy,
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …

Introduction While size thresholds exist to determine when aortic aneurysms warrant
surgical intervention, there is no consensus on how best to treat this disease before …

OBJECTIVE To examine the expansion of aneurysmal aortic segments (⩾ 35 mm) and to
assess the impact of clinical and patho-anatomical factors on aneurysm expansion. DESIGN …

The diameter of thoracic aortic aneurysm (AA) is at least 1.5 times that of a normal thoracic
aorta (1). Sixty percent of thoracic AAs occur in the aortic root and/or the ascending aorta …

Objective/Background The growth rates of thoracic aortic aneurysms (TAAs) and factors
influencing their expansion are poorly understood. This study aimed to review systematically …

Thoracic aortic aneurysm is a major health problem with multiple etiologies and potentially
devastating consequences. Currently, no large randomized trial has shown that medical …

INTRODUCTION: Is it possible by pharmacological methods to attenuate the expansion rate
of abdominal aortic aneurysms? METHOD: An Internet-based systematic literature search …

Aortic aneurysm is a permanent focal dilation of the aorta. It is usually an asymptomatic
disease but can lead to sudden death due to aortic rupture. Aortic aneurysm-related …

Thoracic aortic aneurysms (TAA) often represent the final manifestation of hereditary or
degenerative disease processes. TAA are primarily caused by age-related degenerative …

Background Pharmacotherapy may represent a potential means to limit the expansion rate
of abdominal aortic aneurysms (AAAs). Studies evaluating the efficacy of different …